Australia reimburses deferred medicines
This article was originally published in Scrip
Executive Summary
Australia's health ministry has listed six of the eight drugs deferred for listing on the state-funded Pharmaceutical Benefits Scheme (PBS). The government has also promised not to defer drugs that would cost the system less than A$10 million a year. The R&D-based pharmaceutical association, Medicines Australia, has welcomed the developments, but says more must be done to deal with the deferrals issue properly.